This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017; 390(10095): 681-696.FakhouriFZuberJFrémeaux-BacchiVLoiratCHaemolytic uraemic syndrome20173901009568169610.1016/S0140-6736(17)30062-4Search in Google Scholar
Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, et al. Atypical hemolytic-uremic syndrome: An update on pathophysiology, diagnosis, and treatment. Ther Apher Dial. 2019; 23(1): 4-21.RainaRKrishnappaVBlahaTKannTHeinWBurkeLet alAtypical hemolytic-uremic syndrome: An update on pathophysiology, diagnosis, and treatment201923142110.1111/1744-9987.1276330294946Search in Google Scholar
Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009; 361(17): 1676-1687.NorisMRemuzziGAtypical hemolytic-uremic syndrome2009361171676168710.1056/NEJMra090281419846853Search in Google Scholar
Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002; 347(8): 589-600.MoakeJLThrombotic microangiopathies2002347858960010.1056/NEJMra02052812192020Search in Google Scholar
Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010; 5(19): 1844-1859.NorisMCaprioliJBresinEMossaliCPianettiGGambaSet alRelative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype20105191844185910.2215/CJN.02210310297438620595690Search in Google Scholar
Dragon-Durey MA, Sethi SK, Bagga A, Blanc C, Blouin J, Ranchin B, et al. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol. 2010; 21(12): 2180-2187.Dragon-DureyMASethiSKBaggaABlancCBlouinJRanchinBet alClinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome201021122180218710.1681/ASN.2010030315301403121051740Search in Google Scholar
Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, et al. Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006; 108(4): 1267-1279.CaprioliJNorisMBrioschiSPianettiGCastellettiFBettinaglioPet alGenetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome200610841267127910.1182/blood-2005-10-007252189587416621965Search in Google Scholar
Caprioli J, Bettinaglio P, Zipfel PF, Amadei B, Daina E, Gamba S, et al. The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat. J Am Soc Nephrol. 2001; 12(2): 297-307.CaprioliJBettinaglioPZipfelPFAmadeiBDainaEGambaSet alThe molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat200112229730710.1681/ASN.V12229711158219Search in Google Scholar
Herbert AP, Kavanagh D, Johansson C, Morgan HP, Blaum BS, Hannan JP, et al. Structural and functional characterization of the product of disease-related factor H gene conversion. Biochemistry. 2012; 51(9): 1874-1884.HerbertAPKavanaghDJohanssonCMorganHPBlaumBSHannanJPet alStructural and functional characterization of the product of disease-related factor H gene conversion20125191874188410.1021/bi201689j22320225Search in Google Scholar
Perez-Caballero D, Gonzalez-Rubio C, Gallardo ME, Vera M, López-Trascasa M, Rodríguez de Córdoba S, et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet. 2001; 68(2): 478-484.Perez-CaballeroDGonzalez-RubioCGallardoMEVeraMLópez-TrascasaMRodríguezde Córdoba Set alClustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome200168247848410.1086/318201123528011170895Search in Google Scholar
Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaimé F, Dragon-Durey MA, Ngo S, et al. Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013; 8(4): 554-562.Fremeaux-BacchiVFakhouriFGarnierABienaiméFDragon-DureyMANgoSet alGenetics and outcome of atypical hemolytic uremic syndrome: A nationwide French series comparing children and adults20138455456210.2215/CJN.04760512361394823307876Search in Google Scholar
Schönauer R, Seidel A, Grohmann M, Lindner TH, Bergmann C, Halbritter J. Deleterious impact of a novel CFH splice site variant in atypical hemolytic uremic syndrome. Front Genet. 2019; 10: 465-471.SchönauerRSeidelAGrohmannMLindnerTHBergmannCHalbritterJDeleterious impact of a novel CFH splice site variant in atypical hemolytic uremic syndrome20191046547110.3389/fgene.2019.00465653024831156713Search in Google Scholar
Venables JP, Strain L, Routledge D, Bourn D, Powell HM, Warwicker P, et al. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med. 2006; 3(10): e431-e442.VenablesJPStrainLRoutledgeDBournDPowellHMWarwickerPet alAtypical haemolytic uraemic syndrome associated with a hybrid complement gene2006310e431e44210.1371/journal.pmed.0030431162655617076561Search in Google Scholar
Heinen S, Sanchez-Corral P, Jackson MS, Strain L, Goodship JA, Kemp EJ, et al. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum Mutat. 2006; 27(3): 292-293.HeinenSSanchez-CorralPJacksonMSStrainLGoodshipJAKempEJet alDe novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome200627329229310.1002/humu.940816470555Search in Google Scholar
Vaziri-Sani F, Holmberg L, Sjöholm AG, Kristoffersson AC, Manea M, Frémeaux-Bacchi V. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int. 2006; 69(6): 981-988.Vaziri-SaniFHolmbergLSjöholmAGKristofferssonACManeaMFrémeaux-BacchiVPhenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome200669698198810.1038/sj.ki.500015516528247Search in Google Scholar
Richards A, Buddles MR, Donne RL, Kaplan BS, Kirk E, Venning MC, et al. Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet. 2001; 68(2): 485-490.RichardsABuddlesMRDonneRLKaplanBSKirkEVenningMCet alFactor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition200168248549010.1086/318203123528111170896Search in Google Scholar
Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, Vigneau C, Kuypers D, Boudailliez B, et al. Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet. 2004;41(6): e84-e90.Fremeaux-BacchiVDragon-DureyMABlouinJVigneauCKuypersDBoudailliezBet alComplement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome2004416e84e9010.1136/jmg.2004.019083173582215173250Search in Google Scholar
Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2006; 17(7): 2017-2025.Fremeaux-BacchiVMoultonEAKavanaghDDragon-DureyMABlouinJCaudyAet alGenetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome20061772017202510.1681/ASN.200510105116762990Search in Google Scholar
Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, Carreras L, Arranz EA, Garrido CA, et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci USA. 2007; 104(1): 240-245.Goicoecheade Jorge EHarrisCLEsparza-GordilloJCarrerasLArranzEAGarridoCAet alGain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome2007104124024510.1073/pnas.0603420103176544217182750Search in Google Scholar
Hu H, Nagra A, Haq MR, Gilbert RD. Eculizumab in atypical haemolytic uraemic syndrome with severe cardiac and neurological involvement. Pediatr Nephrol. 2014; 29(6): 1103-1106.HuHNagraAHaqMRGilbertRDEculizumab in atypical haemolytic uraemic syndrome with severe cardiac and neurological involvement20142961103110610.1007/s00467-013-2709-z24317637Search in Google Scholar
Olie KH, Florquin S, Groothoff JW, Verlaak R, Strain L, Goodship TH, et al. Atypical relapse of hemolytic uremic syndrome after transplantation. Pediatr Nephrol. 2004; 19(10): 1173-1176.OlieKHFlorquinSGroothoffJWVerlaakRStrainLGoodshipTHet alAtypical relapse of hemolytic uremic syndrome after transplantation200419101173117610.1007/s00467-004-1565-215300478Search in Google Scholar
Olie KH, Goodship TH, Verlaak R, Florquin S, Groothoff JW, Strain L, et al. Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: Successful treatment with intensive plasma exchanges and ganciclovir. Am J Kidney Dis. 2005; 45(1): e12-e15.OlieKHGoodshipTHVerlaakRFlorquinSGroothoffJWStrainLet alPosttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: Successful treatment with intensive plasma exchanges and ganciclovir2005451e12e1510.1053/j.ajkd.2004.09.01215696434Search in Google Scholar
Davin JC, Strain L, Goodship TH. Plasma therapy in atypical haemolytic uremic syndrome: Lessons from a family with a factor H mutation. Pediatr Nephrol. 2008; 23(9): 1517-1521.DavinJCStrainLGoodshipTHPlasma therapy in atypical haemolytic uremic syndrome: Lessons from a family with a factor H mutation20082391517152110.1007/s00467-008-0833-y245923318483746Search in Google Scholar
Lapeyraque AL, Wagner E, Phan V, Clermont MJ, Merouani A, Fremeaux-Bacchi V, et al. Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations. Pediatr Nephrol. 2008; 23(8): 1363-1366.LapeyraqueALWagnerEPhanVClermontMJMerouaniAFremeaux-BacchiVet alEfficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations20082381363136610.1007/s00467-008-0803-418425537Search in Google Scholar
Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009; 24(4): 687-696.AricetaGBesbasNJohnsonSKarpmanDLandauDLichtCet alGuideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome200924468769610.1007/s00467-008-0964-118800230Search in Google Scholar
Hidalgo M, Pinto S, Tortajada A, Rodríguez de Córdoba S. Genetics of atypical hemolytic uremic syndrome (aHUS). Semin Thromb Hemost. 2014; 40(04): 422-430.HidalgoMPintoSTortajadaARodríguezde Córdoba SGenetics of atypical hemolytic uremic syndrome (aHUS)2014400442243010.1055/s-0034-137529624799305Search in Google Scholar
Afshar-Kharghan V. Atypical hemolytic uremic syndrome. Hematology Am Soc Hematol Educ Program. 2016; 2016(1): 217-225.Afshar-KharghanVAtypical hemolytic uremic syndrome20162016121722510.1182/asheducation-2016.1.217614250927913483Search in Google Scholar
Feitz WJC, van de Kar NCAJ, Orth-Höller D, van den Heuvel LPJW, Licht C. The genetics of atypical hemolytic uremic syndrome. Med Genet. 2018; 30 (4): 400-409.FeitzWJCvande Kar NCAJOrth-HöllerDvanden Heuvel LPJWLichtCThe genetics of atypical hemolytic uremic syndrome201830440040910.1007/s11825-018-0216-0640438930930551Search in Google Scholar
Boon CJF, van de Kar NC, Klevering BJ, Keunen JEE, Cremers FPM, Klaver CCW, et al. The spectrum of phenotypes caused by variants in the CFH gene. Mol Immunol. 2009; 46(8-9): 1573-1594.BoonCJFvande Kar NCKleveringBJKeunenJEECremersFPMKlaverCCWet alThe spectrum of phenotypes caused by variants in the CFH gene2009468-91573159410.1016/j.molimm.2009.02.01319297022Search in Google Scholar
Józsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, Oppermann M, et al. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood. 2007; 110(5): 1516-1518.JózsiMStrobelSDahseHMLiuWSHoyerPFOppermannMet alAnti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome200711051516151810.1182/blood-2007-02-07147217495132Search in Google Scholar
Cody EM, Dixon BP. Hemolytic uremic syndrome. Pediatr Clin North Am. 2019; 66 (1): 235-246.CodyEMDixonBPHemolytic uremic syndrome201966123524610.1016/j.pcl.2018.09.01130454746Search in Google Scholar
Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011; 8: 60-90.LoiratCFrémeaux-BacchiVAtypical hemolytic uremic syndrome20118609010.1007/978-3-662-52972-0_24Search in Google Scholar
Arjona E, Huerta A, Goicoechea de Jorge E, Rodríguez de Córdoba S. Familial risk of developing atypical hemolytic-uremic syndrome. Blood. 2020; 136(13): 1558-1561.ArjonaEHuertaAGoicoecheade Jorge ERodríguezde Córdoba SFamilial risk of developing atypical hemolytic-uremic syndrome2020136131558156110.1182/blood.202000693132488248Search in Google Scholar
Sartz L, Olin AI, Kristoffersson AC, Ståhl AL, Johansson ME, Westman K, et al. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome. J Immunol. 2012; 188(4): 2030-2037.SartzLOlinAIKristofferssonACStåhlALJohanssonMEWestmanKet alA novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome201218842030203710.4049/jimmunol.110031922250080Search in Google Scholar
Bhatia D, Khandelwal P, Sinha A, Hari P, Cheong HI, Bagga A. Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome. Pediatr Nephrol. 2015; 30(12): 2215-2220.BhatiaDKhandelwalPSinhaAHariPCheongHIBaggaAIncomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome201530122215222010.1007/s00467-015-3189-026307634Search in Google Scholar
Cao M, Leite BN, Ferreiro T, Calvo M, Fernández C, Alonso Á, et al. Eculizumab modifies outcomes in adults with atypical hemolytic uremic syndrome with acute kidney injury. Am J Nephrol. 2018;48(3): 225-233.CaoMLeiteBNFerreiroTCalvoMFernándezCAlonsoÁet alEculizumab modifies outcomes in adults with atypical hemolytic uremic syndrome with acute kidney injury201848322523310.1159/00049286530205388Search in Google Scholar
Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, et al. An international consensus approach to the management of atypical hemolytic uremic syndromein children. Pediatr Nephrol. 2016; 31(1):15-39.LoiratCFakhouriFAricetaGBesbasNBitzanMBjerreAet alAn international consensus approach to the management of atypical hemolytic uremic syndromein children2016311153910.1007/s00467-015-3076-825859752Search in Google Scholar
Merrill SA, Brittingham ZD, Yuan X, Moliterno AR, Sperati CJ, Brodsky RA, et al. Eculizumab cessation in atypical hemolytic uremic syndrome. Blood. 2017; 130(3): 368-372.MerrillSABrittinghamZDYuanXMoliternoARSperatiCJBrodskyRAet alEculizumab cessation in atypical hemolytic uremic syndrome2017130336837210.1182/blood-2017-02-770214552047128461395Search in Google Scholar
Ruszkowski J, Heleniak Z, Dębska-Ślizień A. Atypical hemolytic uremic syndrome: A new drug program and first Polish adult patient treated with eculizumab. Pol Merkur Lekarski. 2018; 45 (267): 119-121.RuszkowskiJHeleniakZDębska-ŚlizieńAAtypical hemolytic uremic syndrome: A new drug program and first Polish adult patient treated with eculizumab201845267119121Search in Google Scholar
Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013; 368(23): 2169-2181.LegendreCMLichtCMuusPGreenbaumLABabuSBedrosianCet alTerminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome2013368232169218110.1056/NEJMoa120898123738544Search in Google Scholar